Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum toxin A for infantile esotropia
NL-OMON39876Suspended
- Sponsor
- The Rotterdam Eye Hospital (REH) PO Box 70030 NL-3000 LM Rotterdam tel: 010 4017777
- Start
- Jun 2013
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label, single-arm trial of botulinum toxin type A in Congenital Esotropia (CE), sponsored by The Rotterdam Eye Hospital (REH) PO Box 70030 NL-3000 LM Rotterdam tel: 010 4017777. Primary endpoint: Proportion of successful motor alignment at 6 months. Started Jun 2013; status: suspended.
02
Drugs
botulinum toxin type A
03
Conditions
Congenital Esotropia (CE)
Beyond the preview
Go deeper on NL-OMON39876.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON39876.